Dr. Li is Head of Asia Pacific healthcare investment banking at Bank of America Merrill Lynch (BAML). Prior to that, Dr. Li was head of Greater China healthcare research with BAML, Jefferies and China International Capital Corporation (CICC) for a total of 8 years. Prior to CICC, Dr. Li was a US biotech analyst at Goldman Sachs in New York City.
Dr. Li obtained her Ph.D. in molecular biology from the University of Utah, MBA from the University of Chicago, and Bachelor Degree in Genetic Engineering from Fudan University.